ClinicalTrials.gg
Not yet recruitingNCT07456150Updated Nov 17, 2026

Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care

A Phase 1 interventional study of Coaching in Chronic Pain and Musculoskeletal Pain, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by VA Office of Research and Development · Phase 1, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Chronic Pain by VA Office of Research and Development — 14 open to participants now, 15 under way, none of them phase 3. Chronic Pain · VA Office of Research and Development.

Planned enrollment
43rd of 53
30 · median 126
Started
2029
the only one that year
Phase 1
3 of 57
2 open now
Primary completion
2030-06
later than 14 of 14 live
Registered
56th of 57
by date

Among the 57 studies in Chronic Pain by VA Office of Research and Development, this one is the 43rd largest by planned enrollment of the 53 interventional ones that give a count, is the only one that started in 2029, is one of 3 in phase 1, reaches primary completion later than 14 of the 14 other live ones, and was the 56th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

14 of the 57 studies in Chronic Pain by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Chronic Pain by VA Office of Research and Development, or all of them as a file.
02

Study summary

Half of all Veterans who seek care from the Veterans Health Administration (VHA) experience chronic musculoskeletal pain. First-line treatment for chronic pain should include nonpharmacological interventions. Although Veterans have access to these interventions, there is no standardized process to personalize them to meet the needs of individual Veterans despite the fact that personalization and self-care are key components of the VHA's Stepped Care Model for pain management. This proposal seeks to adapt and evaluate a coaching intervention that will be a personalized approach to help Veterans develop and maintain pain self-care plans. The proposed research responds to VHA's strategic objectives to tailor service delivery (obj. 2.2) and develop or adapt interventions that improve Veteran outcomes (obj. 2.4).

Read the detailed description

The overall purpose of this research is to design and test an intervention that will support Veterans in developing and maintaining a self-care plan for chronic pain. This study will use a multi-stage mixed methods intervention development and optimization design. The first stage (Aim 1) is a convergent mixed methods design that incorporates traditional qualitative, human-centered design, and quantitative methods to discover Veteran and clinician preferences and recommendations for an intervention to support personalization and maintenance of pain self-care plans. The second stage (Aim 2) uses human-centered design methods to engage with multiple key partners (Veterans, clinicians, leadership, etc.) to iterative design the intervention. The final stage (Aim 3) is a convergent mixed-methods design that will test the intervention among Veterans with chronic pain. Aim 3 will evaluate the feasibility and acceptability of the intervention using a randomized feasibility study with 2 parallel arms (n=15/arm). The primary feasibility outcomes are recruitment and retention; secondary outcomes will evaluate willingness of participants to be randomized, acceptability of the intervention, and changes in Veteran-level outcomes (pain interference, quality of life, etc.).

03

Conditions studied

  • Chronic Pain
  • Musculoskeletal Pain

Keywords

  • Veterans
  • Human-centered Design
  • Coaching
  • Self Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • U.S. military Veteran
  • Chronic musculoskeletal pain defined by the National Health Interview Survey (pain that has been present on most days for the past 3 months)

Exclusion criteria

Exclusion Criteria:

  • Moderate to Severe cognitive impairment
  • Severe or untreated substance use disorder
  • Severe or untreated mental health condition
  • Enrolled in hospice or palliative care with \<12 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Intervention

    Participants randomized to the Intervention arm will receive the intervention for developing and maintaining a personalized pain self-care plan. The intervention is anticipated to be a coaching program that will last for about 3 months; specific details of the intervention will be updated prior to enrollment.

    Behavioral: Coaching

  • No intervention
    Control

    Participants randomized to the Control arm will receive advise to continue with their planned medical care and daily activities. Specific details and the type of comparator arm will be updated prior to enrollment because these may changed based on key partner findings in stages 1 and 2 (aims 1 and 2).

Interventions

  • BehavioralCoaching

    The intervention will likely incorporate health coaching to support participants in developing and maintaining their pain self-care plans. Details of the intervention will be updated prior to enrollment because the core components may changed based on findings from stages 1 and 2 (aims 1 and 2).

06

What researchers measure

Primary outcomes

  1. Recruitment (number enrolled out of all eligible and asked to participate)

    Recruitment rate is defined as the proportion of Veterans who enroll in the feasibility study out of all those eligible who were asked to participate.

    Time frame: Baseline

  2. Retention (number who complete intervention and outcomes at post-intervention out of all enrolled)

    Retention is defined as the proportion of Veterans who complete the intervention (anticipated timeframe of 3 months) and the proportion who complete the post-intervention outcomes (anticipated 3 months) and follow-up outcomes (anticipated 6 months)

    Time frame: 3 Months (primary) and 6 Months

Secondary outcomes

  1. Feasibility of Intervention Measure (scale)

    The Feasibility of Intervention Measure consists of 4 items rated on a 5-point Likert scale from (1) complete disagree to (5) completely agree. Mean scores are reported and can range from 1 to 5. Higher scores indicate greater feasibility of the program. Feasibility will be evaluated post-program (anticipated 3 months).

    Time frame: 3 Months

  2. Acceptability of Intervention Measure (scale)

    The Acceptability of Intervention Measure consists of 4 items rated on a 5-point Likert scale from (1) complete disagree to (5) completely agree. Mean scores are reported and can range from 1 to 5. Higher scores indicate greater acceptability of the program. Feasibility will be evaluated post-program (anticipated 3 months).

    Time frame: 3 Months

  3. Intervention Appropriateness Measure (scale)

    The Intervention Appropriateness Measure consists of 4 items rated on a 5-point Likert scale from (1) complete disagree to (5) completely agree. Mean scores are reported and can range from 1 to 5. Higher scores indicate greater appropriateness of the program. Feasibility will be evaluated post-program (anticipated 3 months).

    Time frame: 3 Months

  4. Pain intensity and interference

    Pain intensity and interference will be measured by the PEG-3 (Pain intensity, interference with Enjoyment of life, and interference with General activity) scale. The PEG-3 is a 3-item measure that is valid for individuals with chronic pain and is sensitive to change. Mean of the three individual item scores are reported and can range from 0 to 10. Lower scores indicated less pain intensity and interference.

    Time frame: Baseline, 3 Months, 6 Months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2029; primary completion for Jun 2030, 17 months later.

Of 60 phase 1 interventional studies under Chronic Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 56. This study's planned 17 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2026
First posted
Mar 6, 2026
StartEst.
Jan 1, 2029
Primary completionEst.
Jun 30, 2030
CompletionEst.
Jun 30, 2031
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: identifiers and contact details
1 update, last Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Minor edits only
    + 2 other changes: identifiers and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07456150
Responsible party
Sponsor
First posted
Mar 6, 2026
Start date
Jan 1, 2029 (estimated)
Primary completion
Jun 30, 2030 (estimated)
Completion
Jun 30, 2031 (estimated)
Last update
Nov 17, 2026

Study contacts

Michelle R Rauzi, DPT
Contact
michelle.rauzi@va.gov
(208) 630-4002
Joseph W Frank, MD MPH
Contact
joseph.frank2@va.gov
(720) 857-2784
Michelle R Rauzi, DPT
principal investigator · Rocky Mountain Regional VA Medical Center, Aurora, CO

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion